Skip to main content
Noah Federman, MD, Pediatric Hematology & Oncology, Los Angeles, CA

NoahFedermanMD Professor Health Sciences

Pediatric Hematology & Oncology Los Angeles, CA

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Director, UCLA Pediatric Bone and Soft Tissue Sarcoma Program Director, UCLA CTSI - Clinical and Translational Research Center Director, UCLA CIRM Alpha Stem Cell Clinic Professor, Department of Pediatrics and Orthopaedic Surgery, UCLA School of Medicine

Dr. Federman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Federman's full profile

Already have an account?

  • Office

    10833 Le Conte Ave
    Department of Pediatric Hematologyoncology UCLA
    Los Angeles, CA 90095
    Phone+1 310-825-6708
    Fax+1 310-825-6708

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2002 - 2005
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2002
  • Williams College
    Williams CollegeB.A., English and Neuroscience, 1993 - 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2026
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • 2021 Los Angeles Magazine Top Doctors 2021
  • Voted Southern California Rising Star SuperDoctors.com, 2015
  • Voted Best Doctors BestDoctors.com, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Percutaneous Image guided core needle biopsies in children with bone and soft tissue tumors  
    Mitton B, Seeger LL, Eckardt MA, Motamedi K, Nelson SD, Eilber FC, Eckardt JJ, Federman N, J Pediatr Hematol Oncol, 1/1/2014
  • Giant cell tumor of bone in childhood: Clinical aspects and novel therapeutic targets Invited review  
    Federman N, Breyen E, Narasimhan V, Sodhi M, Dry SM, Chawla SP, Paediatr Drugs, 1/1/2014
  • Safety and efficacy of stereotactic body radiation therapy for pulmonary metastases from high-grade sarcomas  
    Mehta NM, Selch M, Federman N, Chmielowski B, Lee JM, Eilber FC, Wang P, Wu J, Agazaryan N, Lee P, Sarcoma, 1/1/2013
  • Join now to see all

Abstracts/Posters

  • Sclerostin expression and biologic function in skeletal sarcomas.
    Shen J, Shrestha S, La Chaud G, Asatrian G, Singh A, Federman N, Dry SM, Ting K, Chia S, James AW, Orthopedic Research Society Annual Meeting, 1/1/2016
  • Malignant transformation of dysplasia epiphysealis hemimelica (Trevor’s disease): The first reported case and recommendations for surveillance.
    Calvert G, Sato J, Federman N, Singh A, Femino D, Musculoskeletal Tumor Society Annual Meeting, 1/1/2015
  • A novel mutation in the HARS gene in a patient with infantile myofibromatosis.
    Baca N, Walsh A, Nelson SF, Federman N, Chang VY, American Society of Pediatric Hematology/Oncology Annual Meeting, 1/1/2015
  • Join now to see all

Lectures

  • Successful patient recruiting, consenting and retention on pediatric clinical trials. 
    1/1/2015
  • Approaches to Death and Dying in the Pediatric Oncology Patient. 
    1/1/2015
  • Osteosarcoma- what the orthopaedic surgeon needs to know. 
    1/1/2015
  • Join now to see all

Other

Press Mentions

  • Unlocking the Potential of Patient-Derived Organoids for Personalized Sarcoma Treatment
    Unlocking the Potential of Patient-Derived Organoids for Personalized Sarcoma TreatmentSeptember 20th, 2024
  • FDA Grants Accelerated Approval of Targeted Therapy for Adults and Children with NTRK Fusion Cancers
    FDA Grants Accelerated Approval of Targeted Therapy for Adults and Children with NTRK Fusion CancersAugust 28th, 2024
  • CIRM Grant Will Help Expand Patients’ Access to UCLA Clinical Trials for Stem Cell, Gene Therapies
    CIRM Grant Will Help Expand Patients’ Access to UCLA Clinical Trials for Stem Cell, Gene TherapiesOctober 27th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish